Estrogen receptor: a valid test for selection of breast cancer patients for endocrine ablation.
作者信息
Leung B S, Fletcher W S, Krippaehne W W
出版信息
Surg Forum. 1973;24:125-7.
PMID:4142813
Abstract
摘要
相似文献
1
2
Precise selection of breast cancer patients with bone metastasis for endocrine ablation.
Surgery. 1976 Oct;80(4):513-7.
3
Prognostic value of estrogen receptor to endocrine ablation in cancer of the breast.雌激素受体对乳腺癌内分泌消融的预后价值。
Surg Gynecol Obstet. 1974 Oct;139(4):525-8.
4
[Ablative endocrine treatment of advanced or metastasizing breast cancer. Criteria of patient selection].[晚期或转移性乳腺癌的消融内分泌治疗。患者选择标准]
Minerva Chir. 1976 Nov 30;31(22):1371-6.
5
[Endocrine therapy of breast cancer: a history].[乳腺癌的内分泌治疗：一段历史]
Union Med Can. 1985 Feb;114(2):139-45.
6
[Results of surgery on the endocrine system in metastasizing breast carcinoma].[转移性乳腺癌内分泌系统的手术结果]
Dtsch Med Wochenschr. 1969 Jan;94(2):87-92. doi: 10.1055/s-0028-1108908.
7
[Selection of patients with breast cancer with regard to endocrine therapy].[乳腺癌患者内分泌治疗的选择]
Schweiz Med Wochenschr. 1977 Nov 19;107(46):1645-55.
8
Estrogen receptors and breast cancer response to adrenalectomy.雌激素受体与乳腺癌对肾上腺切除术的反应。
Natl Cancer Inst Monogr. 1971 Dec;34:55-70.
9
Antiestrogen treatment of breast cancer: an overview.乳腺癌的抗雌激素治疗：概述
Cancer Res. 1982 Aug;42(8 Suppl):3424s-3429s.
10
Management of breast cancer.乳腺癌的管理
Clin Pharm. 1982 Nov-Dec;1(6):515-29.
Zotero 插件